November 16, 2016

On November 3, 2016, ITI reached a critical milestone. We donated our 100 millionth dose of antibiotics year-to-date to wipe out trachoma, the world’s leading infectious cause of blindness. View the animation to follow our 18-year fight to rid the world of this debilitating, devastating disease.

November 14, 2016

The Zithromax® donation that went to the Central African Republic on November 3rd 2016, puts the ITI drug donation program at 100,143,888 doses shipped year to date – with another 12 million in the pipeline and expected to ship by year-end. 

October 29, 2016

The WHO Alliance for the Global Elimination of Trachoma by the year 2020 (GET2020) has been awarded the ‘Global Partnership Award’ during the 10th General Assembly of the International Agency for the Prevention of Blindness (IAPB).

August 10, 2016

The Task Force for Global Health, ITI's umbrella organization, is often described as a partner among partners, fighting diseases that affect the world’s most disadvantaged people and shining the light on local partners, governments and communities. Yesterday, the light was firmly on the Task Force when it was awarded the Hilton Prize, the world's largest humanitarian prize for 30 years of work in the humanitarian sector.

July 25, 2016

Ethiopia's 16th Trachoma Week, supported by The Carter Center and ITI, took place in May 2016. Approximately 7.4 million people across 70 districts received Zithromax®. (All photos courtesy of The Carter Center.)

May 10, 2016

World Health Organization (WHO) brings together ministry of health representatives, NGO partners, donors and academics for annual GET 2020 meeting.

March 17, 2016

ITI's PJ Hooper, Beck Willis and Girija Sankar visited Colombia in February 2016 to present on ITI's annual drug donation cycle and learn more about Colombia's regulatory requirements for drug donations. 

February 11, 2016

Sharing a few of ITI's favorite photos from the 500 millionth dose celebration last November.

November 16, 2015

- Trachoma is the Leading Infectious Cause of Blindness -

- More Than 100 Government, Non-Governmental and Private Sector Partners Driving Progress -

- Continued Efforts Needed to Reach 2020 Global Elimination Goal

ADDIS ABABA, ETHIOPIA--The International Trachoma Initiative (ITI), Pfizer Inc. and International Coalition for Trachoma Control (ICTC) partners announce Pfizer’s donation of the 500 millionth dose of Zithromax® (azithromycin) Tablets, an antibiotic used to treat trachoma in certain countries. The milestone marks significant achievement in global efforts to help eliminate this infectious and preventable eye disease that can lead to permanent blindness as a public health threat by the year 2020.

Today, delegations from the U.K. and U.S. governments, non-governmental organizations (NGOs) and Pfizer are gathering in the Wolisso region of Ethiopia to celebrate the donation of the 500 millionth Zithromax dose and a significant expansion of the national trachoma elimination program in the country.